VICP Registry Case Source Bundle Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_15-vv-00748 Package ID: USCOURTS-cofc-1_15-vv-00748 Petitioner: Amanda Green Filed: 2015-07-17 Decided: 2017-10-05 Vaccine: meningococcal Vaccination date: 2012-07-23 Condition: persistent headaches and motor tics Outcome: compensated Award amount USD: 132190 AI-assisted case summary: Amanda Green filed a petition for compensation under the National Vaccine Injury Compensation Program on July 17, 2015, alleging that she developed persistent headaches and motor tics as a result of a meningococcal vaccine she received on July 23, 2012. She claimed these injuries caused residual effects for more than six months. The respondent, the Secretary of Health and Human Services, denied that the vaccine caused her alleged conditions and denied that her current disabilities were sequelae of a vaccine-related injury. Despite these denials, the parties reached a joint stipulation to settle the case and award compensation to Ms. Green. The stipulation, dated October 5, 2017, was adopted by Special Master Thomas L. Gowen. Ms. Green was awarded a lump sum of $132,190.59, payable to her. This amount represents compensation for all damages available under Section 300aa-15(a). The decision noted that the parties agreed to settle the issues and that Ms. Green and the respondent renounced their right to seek review of the judgment. Daniel J. Leeper represented the petitioner, and Lisa A. Watts represented the respondent. Theory of causation field: Petitioner Amanda Green received a meningococcal vaccine on July 23, 2012, and subsequently developed daily persistent headaches and motor tics, alleging these injuries caused residual effects for more than six months. The respondent denied that the vaccine caused the alleged conditions or that the disabilities were sequelae of a vaccine-related injury. The parties reached a joint stipulation for settlement, and Special Master Thomas L. Gowen adopted the stipulation, awarding petitioner $132,190.59 as a lump sum. The public decision does not describe the specific theory of causation, medical experts, onset, symptoms, tests, treatments, or the mechanism of injury. Petitioner was represented by Daniel J. Leeper, and respondent was represented by Lisa A. Watts. The decision was issued on October 5, 2017. Public staged source text: ================================================================================ DOCUMENT 1: USCOURTS-cofc-1_15-vv-00748-0 Date issued/filed: 2017-10-31 Pages: 7 Docket text: PUBLIC DECISION (Originally filed: 10/5/2017) regarding 34 DECISION Stipulation/Proffer ( Signed by Special Master Thomas L. Gowen.)(mpj) Copy to parties. -------------------------------------------------------------------------------- Case 1:15-vv-00748-UNJ Document 49 Filed 10/31/17 Page 1 of 7 In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS Filed: October 5, 2017 * * * * * * * * * * * * * AMANDA GREEN, * UNPUBLISHED * Petitioner, * No. 15-748V * v. * Special Master Gowen * SECRETARY OF HEALTH * Joint Stipulation; Meningococcal AND HUMAN SERVICES, * Vaccination; Persistent Headaches; * Motor Tics. Respondent. * * * * * * * * * * * * * * Daniel J. Leeper, Leeper & Leeper, St. Petersburg, FL, for petitioner. Lisa A. Watts, United States Department of Justice, Washington, DC, for respondent. DECISION ON JOINT STIPULATION1 On July 17, 2015, Amanda Green (“petitioner”) filed a petition for compensation pursuant to the National Vaccine Injury Compensation Program.2 Petitioner received a meningococcal vaccine on July 23, 2012. Petitioner alleges that as a result of the meningococcal vaccine, she developed daily persistent headaches and motor tics and that she suffered the residual effects of her injuries for more than six months. On October 5, 2017, the parties filed a stipulation in which they state that a decision should be entered awarded compensation to petitioner. Joint Stipulation (ECF No. 33). Respondent denies that the meningococcal vaccine caused petitioner’s alleged daily persistent headaches, motor tics, or any other injury, and further denies that petitioner’s current disabilities 1 Pursuant to the E-Government Act of 2002, see 44 U.S.C. § 3501 note (2012), because this decision contains a reasoned explanation for the action in this case, I intend to post it on the website of the United States Court of Federal Claims. The court’s website is at http://www.uscfc.uscourts.gov/aggregator/sources/7. Before the decision is posted on the court’s website, each party has 14 days to file a motion requesting redaction “of any information furnished by that party: (1) that is a trade secret or commercial or financial in substance and is privileged or confidential; or (2) that includes medical files or similar files, the disclosure of which would constitute a clearly unwarranted invasion of privacy.” Vaccine Rule 18(b). “An objecting party must provide the court with a proposed redacted version of the decision.” Id. If neither party files a motion for redaction within 14 days, the decision will be posted on the court’s website without any changes. Id. 2 The National Vaccine Injury Compensation Program is set forth in Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755, codified as amended, 42 U.S.C. §§ 300aa-1 to -34 (2012) (Vaccine Act or the Act). All citations in this decision to individual sections of the Vaccine Act are to 42 U.S.C.A. § 300aa. Case 1:15-vv-00748-UNJ Document 49 Filed 10/31/17 Page 2 of 7 are sequelae of a vaccine-related injury. Id. at ¶ 6. Maintaining their above-stated positions, the parties nevertheless now agree that the issues between them shall be settled and that a decision should be entered awarding compensation to petitioner according to the terms of the joint stipulation attached hereto as Appendix A. The joint stipulation awards a lump sum of $132,190.59 in the form of a check payable to petitioner. Joint Stipulation at ¶ 8. This amount represents compensation for all damages that would be available under Section 300aa-15(a). I find the stipulation reasonable and I adopt it as the decision of the Court in awarding damages, on the terms set forth therein. Accordingly, the Clerk of the Court SHALL ENTER JUDGMENT in accordance with the terms of the parties’ stipulation.3 IT IS SO ORDERED. s/Thomas L. Gowen Thomas L. Gowen Special Master 3 Pursuant to Vaccine Rule 11(a), entry of judgment is expedited by the parties’ joint filing of notice renouncing the right to seek review. 2 Case 1:15-vv-00748-UNJ Document 49 Filed 10/31/17 Page 3 of 7 Case 1:15-vv-00748-UNJ Document 49 Filed 10/31/17 Page 4 of 7 Case 1:15-vv-00748-UNJ Document 49 Filed 10/31/17 Page 5 of 7 Case 1:15-vv-00748-UNJ Document 49 Filed 10/31/17 Page 6 of 7 Case 1:15-vv-00748-UNJ Document 49 Filed 10/31/17 Page 7 of 7